Skip to content

MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA)

Early Enteral Tube Feeding Compared With Pancreas Rest in Patients With Acute Pancreatitis: a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01128478
Acronym
MIMOSA
Enrollment
35
Registered
2010-05-24
Start date
2010-05-31
Completion date
2012-04-30
Last updated
2013-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Keywords

Acute pancreatitis, Enteral nutrition, Pancreas rest

Brief summary

Pain relapse during oral refeeding occurs in at least one-fifth of patients with acute pancreatitis. The study hypothesis is that early administered enteral tube feeding might reduce a risk of pain relapse and shorten the length of hospital stay in patients with acute pancreatitis.

Interventions

Nasogastric tube feeding started within 24 h of hospital admission

Sponsors

University of Auckland, New Zealand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of acute pancreatitis * age 18 years or older * written informed consent

Exclusion criteria

* \> 96 hours after onset of symptoms * \> 24 hours after hospital admission * organ failure by the time of randomization * infectious complications before randomization * received artificial nutrition before randomization * previously enrolled into the trial * chronic pancreatitis * post-ERCP pancreatitis * intraoperative diagnosis of acute pancreatitis * pregnancy * malignancy

Design outcomes

Primary

MeasureTime frame
Length of hospital stayUp to 3 months

Secondary

MeasureTime frame
Local and systemic complicationsUp to 3 months
Feeding intoleranceUp to 3 months
Time to solid oral food toleratedApprox. one week
Pain relapseUp to 3 months
Hospital readmissionUp to 6 months
Quality of lifeUp to 6 months
MortalityUp to 6 months
Pain-free timeUp to 3 months

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026